Geneva, May 4 -- International Clinical Trials Registry received information related to the study (CTRI/2026/04/109171) titled 'A Study to Compare Safety, Tolerability, and Efficacy of Oral Insulin Tablets (Test) with insulin glargine Injection (Reference) in Patients with Type 2 Diabetes Mellitus' on April 23.
Study Type: Interventional
Study Design:
Other Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:Other Blinding and masking:Not Applicable
Primary Sponsor: NBI Biosciences Private Limited
Condition:
Health Condition 1: E00-E89- Endocrine, nutritional and metabolic diseases
Intervention:
Intervention1: NBI42A Oral Insulin Tablets
(Test Product).
: Total Study d...